Prognostic value and significance of subcarinal and superior mediastinal lymph node metastasis in lower lobe tumours

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 4, 2010, Pages 498-502

  Uehara, Hirofumi ^a   Sakao, Yukinori ^a   Mun, Mingyon ^a   Nakagawa, Ken ^a   Nishio, Makoto ^a   Ishikawa, Yuichi ^b   Okumura, Sakae ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

Diagnosis and staging; Lung cancer; Lung cancer surgery; Lymph nodes; Outcomes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHUS; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG LOBE; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MEDIASTINUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; YOUNG ADULT;

EID: 77957261332     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.02.027     Document Type: Article

References (20)

1. Mountain C.F. A new international staging system for lung cancer. Chest 1986, 89:225-233.
2. Mountain C.F. Revision in the international system for staging lung cancer. Chest 1997, 111:1710-1717.
3. Rusch V.W., Crowley J., Giroux D.J., Goldstraw P., Im J.G., Tsuboi M., Tsuchiya R., Vansteenkiste J. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2007, 2:603-612.
4. Rusch V.W., Asamura H., Watanabe H., Giroux D.J., Rami-Porta R., Goldstraw P. The IASLC Lung Cancer Staging Project: a proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM classification for lung cancer. J Thorac Oncol 2009, 4:568-577.
5. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978, 76:832-839.
6. The Japan Lung Cancer Society. Classification of Lung Cancer, 1st English Ed. Tokyo: Kanehara & Co.; 2000.
7. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 1997, 111:1718-1723.
8. Jett J., Feins R., Kvale P. Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997, 156:320-332.
9. Tisi G.M., Friedman P.J., Peters R.M. Clinical staging of primary lung cancer. Am Rev Respir Dis 1983, 127:659-664.
10. Japan Lung Cancer Society, editor. General rule for clinical and pathologic record of lung cancer. 6th ed., Tokyo: Kanahara; 2003:98 [in Japanese].
11. International Union Against Cancer. TNM classification of malignant tumors. 5th ed., New York: Wiley-Liss; 1997:93-7.
12. Naruke T., Tsuchiya R., Kondo H., Nakayama H., Asamura H. Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg 1999, 16:17-24.
13. World Health Organization. The World Health Organization histological typing of lung tumours. Geneva: World Health Organization; 1999:21-4.
14. Asamura H., Suzuki K., Kondo H., Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer. Ann Thorac Surg 2000, 70:1839-1846.
15. Rea F., Marulli G., Callegaro D., Zuin A., Gobbi T., Loy M., Sartori F. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?. Lung Cancer 2004, 45:215-220.
16. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 1994, 107:1398-1402.
17. Ueda K., Kaneda Y., Saeki K., Fujita N., Zempo N., Esato K. Hilar lymph nodes in N2 disease: survival analysis of patients with non-small cell lung cancer and regional lymph node metastasis. Surg Today 2002, 32:300-304.
18. Tanaka F., Yanagihara K., Otake Y., Yamada T., Shoji T., Miyahara R., Inui K., Wada H. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 2001, 19:555-561.
19. Van Velzen E., Snijder R.J., Brutel de la Riviere A., Elbers H.R., Van den Bosch J.M. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann Thorac Surg 1997, 63:1436-1440.
20. Okada M., Sakamoto T., Yuki T., Mimura T., Nitanda H., Miyoshi K., Tsubota N. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 2005, 129:825-830.